FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition
Top Cited Papers
- 1 April 2001
- journal article
- review article
- Published by Elsevier BV in Trends in Pharmacological Sciences
- Vol. 22 (4), 201-207
- https://doi.org/10.1016/s0165-6147(00)01676-x
Abstract
No abstract availableKeywords
Funding Information
- Göran Gustafssons Stiftelse för Naturvetenskaplig och Medicinsk Forskning
- Novo Nordisk Fonden
- Association for International Cancer Research
- Cancerfonden
This publication has 73 references indexed in Scilit:
- FGFs, heparan sulfate and FGFRs: complex interactions essential for developmentBioEssays, 2000
- Integrin αvβ3 Requirement for Sustained Mitogen-activated Protein Kinase Activity during AngiogenesisThe Journal of cell biology, 1998
- Interactions of FLT-1 and KDR with Phospholipase C γ: Identification of the Phosphotyrosine Binding SitesBiochemical and Biophysical Research Communications, 1997
- Differential Transcriptional Regulation of the Two Vascular Endothelial Growth Factor Receptor GenesPublished by Elsevier BV ,1997
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996
- Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3Nature Genetics, 1996
- Abnormal blood vessel development and lethality in embryos lacking a single VEGF alleleNature, 1996
- Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endotheliumNature, 1995
- Failure of blood-island formation and vasculogenesis in Flk-1-deficient miceNature, 1995
- Biological Activity and Phosphorylation Sites of the Bacterially Expressed Cytosolic Domain of the KDR VEGF-ReceptorBiochemical and Biophysical Research Communications, 1994